Trial
NCT00503984
A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Miami
Collaborators
—
Condition
Prostate Cancer
Intervention
Azacitidine
Why stopped
Withdrawal of Funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-06-09